Log In
Print
BCIQ
Print
Print this Print this
 

Teysuno, tegafur/gimeracil/oteracil potassium (S-1, TS-1)

  Manage Alerts
Collapse Summary General Information
Company Taiho Pharmaceutical Co. Ltd.
DescriptionOral combination of 5-fluorouracil (5-FU) plus 2 enzyme inhibitors
Molecular Target Dihydropyrimidine dehydrogenase
Mechanism of ActionDihydropryimidine dehydrogenase inhibitor
Therapeutic ModalitySmall molecule: Combination

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today